A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis

Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatment regimens. PZA-resistance in M. tuberculosis is increasing, especially among M/XDR cases. Noted issues with PZA Drug Susceptibility Testing (DST) have driven the search for alternative tests. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez-Busby, S. M., Rodwell, T. C., Fink, L., Catanzaro, D., Jackson, R. L., Pettigrove, M., Catanzaro, A., Valafar, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476565/
https://www.ncbi.nlm.nih.gov/pubmed/28630430
http://dx.doi.org/10.1038/s41598-017-03452-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476565/
https://www.ncbi.nlm.nih.gov/pubmed/28630430
http://dx.doi.org/10.1038/s41598-017-03452-y

Ejemplares similares